Letter to NAPRA on emergency contraception
Tagged :
Print 
Text Size: Normal / Medium / Large
Printer-friendly versionLetter (PDF) written to the National Association of Pharmacy Regulatory Authorities on behalf of the International Reproductive and Sexual Health Law Programme, Faculty of Law, University of Toronto to support the requested status change of levonorgestrel, commonly known as “the morning after pill”, from Schedule II to Schedule III.
The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.